IL1A and lung carcinoma: Moreover, in our previous study, we found that plasmacytoid dendritic cells (pDCs) derived from the cancerous lesions of patients with lung cancer were able to release IL-1α, rendering pDCs tolerogenic in that they highly populated tumour lesions, thus implying their role in tumour proliferation22.